Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1
G protein-coupled estrogen receptor 1 (GPER1) is a potential therapeutic target for treating triple-negative breast cancers (TNBC). However, modulators for GPER1 that can be used to treat TNBC have not appeared. Berberine (BBR) is a bioactive isoquinoline alkaloid with high oral safety. In recent ye...
Saved in:
Main Authors: | Miaomiao Qi, Xiang Liu, Ying Zhou, Haoyu Wang, Ying Zhao, Jing Ren, Jin Xiang |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/07058c31455d4bdaa6655fe7ee9f56ec |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway
by: Zhu,Liping, et al.
Published: (2018) -
Role of berberine in ameliorating Schistosoma mansoni-induced hepatic injury in mice
by: Dkhi,Mohamed A
Published: (2014) -
Molecular Proof of a Clinical Concept: Expression of Estrogen Alpha-, Beta-Receptors and G Protein-Coupled Estrogen Receptor 1 (GPER) in Histologically Assessed Common Nevi, Dysplastic Nevi and Melanomas
by: Magdalena Spałkowska, et al.
Published: (2021) -
Berberine Chloride is an Alphavirus Inhibitor That Targets Nucleocapsid Assembly
by: Judy J. Wan, et al.
Published: (2020) -
miR-29b-3p promotes progression of MDA-mB-231 triple-negative breast cancer cells through downregulating TRAF3
by: Zhang,Bao, et al.
Published: (2019)